The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases

被引:29
|
作者
Kiran, Tugce [1 ]
Demirkesen, Cuyan [1 ]
Eker, Candan [2 ]
Kumusoglu, Hakki [2 ]
Tuzuner, Nukhet [1 ]
机构
[1] Istanbul Univ, Dept Pathol, Cerrahpasa Med Fac, TR-34098 Istanbul, Turkey
[2] Medimiks Med Biotechnol, Res & Dev Lab, Istanbul, Turkey
关键词
IRF4; translocation; MUM1; Cutaneous lymphomas; CD30; ALCL; MUM1; LYMPHOMAS;
D O I
10.1016/j.leukres.2012.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Current laboratory technics, clinicopathologic findings cannot always reliably distinguish primary cutaneous CD30(+) lymphoproliferative disorders (LPD), such as lymphomatoid papulosis (LyP), primary cutaneous CD30(+) anaplastic large cell lymphoma (PCALCL), transformed mycosis fungoides (T-MF) and systemic ALK(-) anaplastic large cell lymphoma (ALCL) with skin involvement. We investigated the presence of IRF4 translocation with break apart DNA-FISH method of these entities according to the recent studies of Feldman et al. In our study group with 53 cases, the detection of IRF4 translocation had a specificity and positive predictive value for PCALCL of 100%. In contrast MUM1/IRF4 protein expression was distributed widely without any predictive value. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:396 / 400
页数:5
相关论文
共 50 条
  • [1] Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
    Iida, S
    Rao, PH
    Butler, M
    Corradini, P
    Boccadoro, M
    Klein, B
    Chaganti, RSK
    DallaFavera, R
    NATURE GENETICS, 1997, 17 (02) : 226 - 230
  • [2] Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
    Shinsuke Iida
    Pulivarthi H. Rao
    Marion Butler
    Paolo Corradini
    Mario Boccadoro
    Bernard Klein
    R.S.K. Chaganti
    Riccardo Dalla-Favera
    Nature Genetics, 1997, 17 : 226 - 230
  • [3] Copy Number Abnormalities Of The Interferon Regulatory Factor-4 (IRF4) Gene Are Associated With IRF4/MUM1 Expression In Peripheral T-Cell Lymphomas
    Boddicker, Rebecca L.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Mark, Law E.
    Xing, Xiaoming
    Cerhan, James R.
    Wu, Yanhong
    Cunningham, Julie M.
    Ansell, Stephen M.
    Feldman, Andrew L.
    BLOOD, 2013, 122 (21)
  • [4] Novel Translocations involving MUM1/IRF4 in peripheral T-Cell lymphomas
    Feldman, A. L.
    Law, M.
    Remstein, E. D.
    Macon, W. R.
    Grogg, K. L.
    Kurtin, P. J.
    Dogan, A.
    LABORATORY INVESTIGATION, 2008, 88 : 253A - 253A
  • [5] Novel translocations involving MUM1/IRF4 in peripheral T-cell lymphomas
    Feldman, A. L.
    Low, M.
    Renistein, E. D.
    Macon, W. R.
    Grogg, K. L.
    Kurtin, P. J.
    Dogan, A.
    MODERN PATHOLOGY, 2008, 21 : 253A - 253A
  • [6] Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome
    Castillo, Luis E. Malpica
    Campuzano-Zuluaga, German
    Toomey, Ngoc L.
    Pimentel, Agustin
    Chapman-Fredricks, Jennifer Rose
    Ramos, Juan Carlos
    BLOOD, 2017, 130
  • [7] Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
    Natkunam, Y
    Warnke, RA
    Montgomery, K
    Falini, B
    van de Rijn, M
    MODERN PATHOLOGY, 2001, 14 (07) : 686 - 694
  • [8] IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma
    Heo, Mi Hwa
    Park, Ha Young
    Ko, Young Hyeh
    Kim, Won Seog
    Kim, Seok Jin
    JOURNAL OF CANCER, 2017, 8 (06): : 1018 - 1024
  • [9] MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies
    Tsuboi, K
    Iida, S
    Inagaki, H
    Kato, M
    Hayami, Y
    Hanamura, I
    Miura, K
    Harada, S
    Kikuchi, M
    Komatsu, H
    Banno, S
    Wakita, A
    Nakamura, S
    Eimoto, T
    Ueda, R
    LEUKEMIA, 2000, 14 (03) : 449 - 456
  • [10] MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia
    Craig, Fiona
    Soma, Lorinda
    Melan, Melissa
    Kant, Jeffrey
    Swerdlow, Steven
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 273 - 280